ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1,2,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2,4,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2,5,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
2,6,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
3,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
4,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
4,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
5,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
6,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
7,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
8,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
9,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
10,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
11,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
11,2,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
11,3,Tonic convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
12,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
13,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
13,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
13,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
14,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
15,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
15,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
16,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
17,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
18,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
18,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
19,1,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
19,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
19,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
19,4,Oropharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
20,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
21,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
21,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
21,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
21,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
22,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
23,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
24,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
25,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
26,1,Endotracheal intubation complication,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
26,2,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,Y
27,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
28,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
29,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
30,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
30,2,Sedation complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
30,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
31,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
31,3,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
31,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
31,5,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
32,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
32,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
33,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
34,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
34,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
35,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
35,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
36,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
37,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
38,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
39,1,Ventricular arrhythmia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
40,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
41,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
42,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
43,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
43,2,Bromoderma,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
43,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
44,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
44,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
44,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
44,4,Gastrointestinal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
44,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
45,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
45,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
46,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
47,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
48,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
49,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
49,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
50,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
51,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
51,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
52,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
53,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
53,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
54,1,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
55,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
55,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
55,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
55,4,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
56,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
57,1,Acute respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
58,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
58,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
58,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
59,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
59,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
60,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
60,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
61,1,Ventricular arrhythmia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
62,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
62,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
62,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
63,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
63,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
63,3,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
63,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
64,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
64,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
64,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
64,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
65,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
65,3,Laryngospasm,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
66,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
67,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
67,2,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
67,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
68,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
69,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
69,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
69,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
70,1,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
70,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
71,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
72,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
73,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
74,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
75,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
76,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
76,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
77,1,Migraine,Migraine headaches,Headaches,Nerv,N
78,1,Hyperthermia malignant,Body temperature altered,Body temperature conditions,Genrl,N
78,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
79,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
79,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
79,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
80,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
80,2,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
80,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
80,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
81,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
82,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
82,2,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
83,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
84,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
84,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,1,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
85,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
86,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
87,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
87,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
89,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
89,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
89,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
90,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,1,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
93,1,Delayed recovery from anaesthesia,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
93,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
95,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
95,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
95,3,Hypoventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
96,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
97,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
98,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
98,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
98,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
99,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
99,3,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
99,4,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
100,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
101,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
101,3,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
101,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
102,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
102,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
102,3,Sex chromosome abnormality,Sex chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
103,1,Y-linked chromosomal disorder,Sex chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
104,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
104,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
104,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
106,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
106,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
107,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
107,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
107,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
107,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
107,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
107,6,Foetal malpresentation,Foetal position and presentation abnormalities,Foetal complications,Preg,N
107,7,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
107,8,Hypocoagulable state,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
107,9,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
107,10,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
107,11,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
107,12,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
107,13,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
108,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
108,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
108,3,Post-anoxic myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
108,4,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
109,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
110,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
110,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
111,1,Breakthrough pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
111,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
112,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
112,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
112,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
112,4,Infantile apnoea,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
112,5,Neonatal respiratory distress syndrome,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
112,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
112,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
113,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
114,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
114,2,Myoclonic epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
115,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
115,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
116,1,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
116,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,3,Migraine,Migraine headaches,Headaches,Nerv,N
116,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
118,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
119,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
120,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
121,1,Anaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
121,2,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
121,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
121,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
121,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
122,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
122,2,Acute fatty liver of pregnancy,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
122,3,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
122,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
122,5,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
122,6,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
122,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
122,8,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
122,9,Hepatic artery thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
122,10,Hepatic vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
122,11,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
122,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
122,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,14,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
122,15,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
122,16,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
122,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
122,18,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
122,19,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
122,20,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
122,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
124,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
124,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
125,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
125,2,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
125,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
126,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
126,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
126,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
126,4,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
126,5,Protrusion tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
126,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
127,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
127,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
127,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
127,7,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
127,8,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
127,9,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
127,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
127,11,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
127,12,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,13,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,14,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
127,15,Product deposit,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
127,16,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,17,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
127,18,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
128,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
129,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
129,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
130,1,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
131,1,Respiratory depression,Breathing abnormalities,Respiratory disorders NEC,Resp,N
132,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
132,2,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
133,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
133,2,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
134,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
134,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
135,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
135,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
135,3,Parkinsonian rest tremor,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
135,4,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
136,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
136,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
136,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
136,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
136,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
136,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
136,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
136,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
136,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
136,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
137,1,Chest injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
137,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
137,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
137,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
137,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
138,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
139,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
140,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
140,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
140,3,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
141,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
142,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
143,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
143,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
144,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
144,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
145,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
145,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
145,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
146,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
146,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
147,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
148,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
148,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
148,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
149,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
149,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
149,4,Inadequate analgesia,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
149,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
149,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
150,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
150,2,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
150,3,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
150,4,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
151,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
151,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
151,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
151,5,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
152,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
153,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
153,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
154,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
155,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
155,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
156,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
156,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
156,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
156,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
156,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
157,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
158,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
158,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
159,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
159,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
159,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
160,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
160,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
160,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
161,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
162,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
162,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
162,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
163,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
163,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
163,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
164,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
164,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
164,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
164,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
165,1,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
166,1,Change in seizure presentation,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
166,2,Epilepsy with myoclonic-atonic seizures,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
167,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
168,1,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
168,2,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
168,3,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
169,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
170,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
170,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
